Carmen Medici


Carmen Medici is a partner in Scott+Scott’s San Diego office and focuses on complex antitrust class action litigation and unfair competition law. He represents businesses and consumers who are the victims of price-fixing, monopolization, collusion, and other anticompetitive and unfair business practices. Carmen specializes in litigation against giants in the tech, financial, pharmaceutical, agriculture, and commodities industries. He has worked on multiple complex class action cases to jury verdict.


Mr. Medici is a partner based in our San Diego office who specializes in antitrust class action litigation focused on pharma, financial and commodities sectors. Carmen currently serves as co-lead counsel in Klein et al v. Meta Platforms, Inc., 20-cv-08570 (N.D. Cal.) where he represents advertisers who allege they overpaid for advertising purchased from Meta Platforms (f/k/a Facebook). He is also a member of the leadership team in In re Cattle Antitrust Litigation, No. 22-md-03031 (D. Minn.) where he represents farmers against the nation’s meatpackers alleging a conspiracy to suppress cattle prices. Carmen is also working on In re European Government Bonds Antitrust Litigation, No. 19-cv-02601 (S.D.N.Y.) which alleges that traders at major banks, through real-time Bloomberg instant messaging, conspired to and did manipulate the primary and secondary market for European government bonds to widen the bid-ask spreads which inflated bond prices while increasing trading fees. He also litigates In re FICO Antitrust Litigation, No. 20-cv-02114 (N.D. Ill.), where a putative class of consumers is seeking relief under allegations that FICO overcharged for its credit scores.

In addition to his current leadership roles, Carmen is investigating and litigating a number of the Firm’s other major antitrust and consumer actions, including cases against Big Tech, Big Oil, pharma and others.


  • In re Payment Card Interchange Fee and Merchant Discount Antitrust Litig., No. 05-md-01720 (E.D.N.Y.) ($5.5 billion settlement)
  • In re Foreign Exchange Benchmark Rates Antitrust Litig., No. 13-cv-07789 (S.D.N.Y.) ($2.3 billion in settlements)
  • In re Aluminum Warehousing Antitrust Litigation, No. 14-cv-3116-PAE (S.D.N.Y.)
  • In re Remicade Antitrust Litigation, No. 2:17-cv-04326-KSM (E.D. Pa.)
  • Lincoln Adventures, LLC v. Those Certain Underwriters at Lloyd’s, LondonMembers of Syndicates, No. 2:08-cv-00235 (D. N.J.)